ArticlePloS one2025

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022.

Anna Bratcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.